SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
Ionis Pharmaceuticals (IONS)
An SI Board Since May 1996
Posts SubjectMarks Bans Symbol
4676 121 0 IONS
Emcee:  Keith Fauci Type:  Unmoderated
Introduction Market Data Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
4576tx.. i've done well with isis over although it has yet to hit the jackpot...bob zagorin-7/13/2010
4575Bob, thanks for keeping the ISIS thread going. I am more a computer guy so do nMr. Sunshine27/12/2010
4574Isis Highlights New Data on Antisense Drugs to Treat Type 2 Diabetes and Obesitybob zagorin-6/29/2010
4573The Motley Fool A Novel Drug Technology Worth Watching fool.com Brian bob zagorin-6/24/2010
4572Isis and Alnylam Provide Update on Regulus' Strategic Alliance with Sanofi-Abob zagorin-6/22/2010
4571Regulus, Sanofi-Aventis team up in $750M alliance Regulus teams with Sanofi-Avenbob zagorin-6/22/2010
4570Needham Company Reiterates a 'Buy' on ISIS Pharmaceuticals (ISIS), Well bob zagorin-6/18/2010
4569cc transcript seekingalpha.combob zagorin-5/6/2010
4568sis Reports Financial Results and Highlights for First Quarter 2010 -Conference bob zagorin-5/6/2010
45677:07AM ISIS Pharm beats by $0.07, beats on revs (ISIS) 9.95 : Reports Q1 (Mar) bob zagorin-5/6/2010
4566MicroRNAs May be Key to Cancer Knowledge and Future Cures Released: 4/13/2010 1:bob zagorin-4/19/2010
4565I am dubious of LET-7 as a target. It seems to function as a sort of tumor suprtuck-4/15/2010
4564Regulus Therapeutics Presents New Pre-clinical Data on microRNA Therapeutics forbob zagorin-4/15/2010
4563Needham Company reiterates a 'Buy' on ISIS Pharmaceuticals (ISIS); Cardibob zagorin-4/15/2010
4562When's the last time we saw Isis looking at HCV? Been years. But Jason dugtuck-4/5/2010
4561ARLSBAD, Calif. and LONDON, March 31 /PRNewswire-FirstCall/ -- GlaxoSmithKline (nigel bates-3/31/2010
4560>>GSK and Isis Pharmaceuticals Collaborate on RNA Therapeutics for Rare antuck-3/31/2010
4559Regulus Announces U.S. Allowance of Stanford Patent Application Covering miR-181bob zagorin-3/17/2010
4558Mipomersen Phase 3 Study in HoFH Patients Featured in The Lancet Last update: 3/bob zagorin-3/15/2010
4557Nice trade Tom. I would have held onto it longer, regrettably...fred hayes-2/10/2010
4556Thanks for the updates Bob...fred hayes-2/10/2010
4555Forbes.com U.S. Equities ISIS Drug Results Disappoint Investors Melanie Lindnerbob zagorin-2/10/2010
4554UPDATE 3-Isis shares drop on cholesterol drug safety worry 1:39pm EST (Recasts;bob zagorin-2/10/2010
4553Thanks Idos.fred hayes-2/10/2010
4552Not really a surprise as data are consistent with previous trials, but obviouslyidos-2/10/2010
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News